 | |
| Clinical data | |
|---|---|
| Other names | MDMP; MDMPH; 3,4-Methylenedioxy-α,α,N-trimethylphenethylamine |
| Routes of administration | Oral[1] |
| ATC code |
|
| Pharmacokinetic data | |
| Duration of action | "Perhaps 6 hours"[1] |
| Identifiers | |
| |
| CAS Number | |
| PubChemCID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard(EPA) | |
| Chemical and physical data | |
| Formula | C12H17NO2 |
| Molar mass | 207.273 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
3,4-Methylenedioxy-N-methylphentermine (MDMP orMDMPH), also known as3,4-methylenedioxy-α,α,N-trimethylphenethylamine, is a lesser-knowndrug.[1]
MDMP was first synthesized byAlexander Shulgin.[1] In his bookPiHKAL, the minimum dose is listed as 110 mg, and the duration is listed as approximately 6 hours.[1] MDMP produces few to no effects, and is slightly similar toMDMA.[1]
MDMP failed to act as aserotonin releasing agent in rat brainsynaptosomesin vitro.[2][3][4]
This substance is a Class A drug in theDrugs controlled by the UK Misuse of Drugs Act.[5]
